Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching.

Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J

Kerr, Lucy; Cadegiani, Flavio A; Baldi, Fernando; Lobo, Raysildo B; Assagra, Washington Luiz O; Proença, Fernando Carlos; Kory, Pierre; Hibberd, Jennifer A; Chamie-Quintero, Juan J.

Kerr L; Medicine, Instituto Kerr, São Paulo, BRA.
Cadegiani FA; Clinical Endocrinology, Corpometria Institute, Brasilia, BRA.
Baldi F; Clinical Endocrinology, Applied Biology Inc, Irvine, USA.
Lobo RB; Animal Sciences, Universidade Estadual de São Paulo (UNESP), São Paulo, BRA.
Assagra WLO; Genetics, Universidade de São Paulo, Ribeirão Preto, BRA.
Proença FC; Genetics, Centro Técnico de Avaliação Genômica - C.T.A.G., Ribeirão Preto, BRA.
Kory P; Bioinformatics, Itajaí City Hall, Itajaí, BRA.
Hibberd JA; Internal Medicine, Front Line COVID-19 Critical Care Alliance (FLCCC), Madison, USA.
Chamie-Quintero JJ; Dentistry, University of Toronto, Toronto, CAN.

Cureus ; 14(3): c61, 2022 Mar.

Article in English | MEDLINE | ID: covidwho-1776628

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.7759/cureus.21272.].

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Language: English Journal: Cureus Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google